Vincent Fischetti
85Patents
21h-index
40Co-inventors
88Inventor score
Filing activity: Jun 18, 1984 → May 24, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6056955A | Topical treatment of streptococcal infections | Human Necessities | 75 | Expired |
| US5643767A | Process for isolating cellular components | Chemistry; Metallurgy | 56 | Expired |
| US5821088A | Use of gram-positive bacteria to express recombinant proteins | Chemistry; Metallurgy | 56 | Expired |
| US5985271A | Prophylactic and theraputic treatment of group A streptococcal infection | Chemistry; Metallurgy | 51 | Expired |
| US6056954A | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses | Emerging Cross-Sectional Technologies | 50 | Expired |
| US6248324A | Bacterial phage associated lysing enzymes for treating dermatological infections | Chemistry; Metallurgy | 47 | Expired |
| US6264945A | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections | Chemistry; Metallurgy | 47 | Expired |
| US5604109A | Method for exposing Group A streptococcal antigens and an improved diagnostic test for the identification of Group A streptococci | Emerging Cross-Sectional Technologies | 46 | Expired |
| US6254866A | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract | Emerging Cross-Sectional Technologies | 44 | Expired |
| US6017528A | Therapeutic treatment of group A streptococcal infections | Human Necessities | 43 | Expired |
| US5968763A | Method for screening inhibitors of the enzyme which cleaves the anchor of surface proteins from gram positive bacteria | Chemistry; Metallurgy | 39 | Expired |
| US5997862A | Therapeutic treatment of group A streptococcal infections | Chemistry; Metallurgy | 37 | Expired |
| US6238661A | Use of bacterial phage associated lysing enzymes for treating various illnesses | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6432444B1 | Use of bacterial phage associated lysing enzymes for treating dermatological infections | Human Necessities | 32 | Expired |
| US6335012B1 | Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4784948A | Production of streptococcal m protein immunogens and molecular probes | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6737521B1 | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria | Chemistry; Metallurgy | 31 | Expired |
| US6277399A | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections | Chemistry; Metallurgy | 30 | Expired |
| US6326002A | Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract | Chemistry; Metallurgy | 29 | Expired |
| US5616686A | Polypeptide of a hybrid surface protein by bacteria | Chemistry; Metallurgy | 28 | Expired |
| US5587288A | Regulation of exoprotein in Staphylococcus aureus | Chemistry; Metallurgy | 22 | Expired |
| US6190659A | Bacterial plasmin binding protein and methods of use thereof | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5786205A | Delivery and expression of a hybrid surface protein by bacteria | Chemistry; Metallurgy | 20 | Expired |
| US5352588A | Streptococcal immunoglobulin a binding protein encoded by emmL2.2 | Chemistry; Metallurgy | 19 | Expired |
| US5985654A | Recombinant poxvirus and streptococcal M protein vaccine | Emerging Cross-Sectional Technologies | 19 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.